2017: President Trump’s Sanctions on Venezuela Resulted in
Increased Deaths Due to AIDS
Acquired immunodeficiency syndrome
(AIDS) is a chronic condition caused by the human immunodeficiency virus,
called HIV. HIV damages the immune system so that the body is less able to
fight infection and disease. There is no
cure for HIV/AIDS. 90% of patients with the virus can expect to contract AIDS
which is fatal in 8 to 10 years. Medicines (antiviral treatments [ART]) can
keep the disease from getting worse.
In 1991, Venezuela began to provide ART as part of a program
that served the population free-of-charge.[1] The percentage of HIV-positive
people receiving ART reached 60% by 2015[2]. All of the ART medicines were
imported. The government provided foreign currency to the National Health
Ministry for the purchase of ART which then was distributed to pharmacies and
hospitals. The foreign currency came from the sale of oil by Venezuela’s state
oil company (PDVSA). According to
UNAIDS, 110,000 people in Venezuela were living with HIV in 2015. [3]
In 2016, the price of oil declined
by 60% which led to a decline of $63 billion in Venezuela’s oil sales. The
government sought restructuring of its foreign debt which could put off
interest payments and make foreign currency available for imports of medicine
and food. On August 24, 2017, US President Trump prohibited US financial
institutions from participating in a restructuring of Venezuela’s debt. Venezuela
paid $200 million in interest payments in late 2017. Trump prohibited CITGO, a
US subsidiary of PDVSA, from sending dividends back to Venezuela. (CITGO had
provided $2.5 billion in dividends to PDVSA from 2015 through 2017). Critics
pointed to the US sanctions for reducing Venezuela’s resources and reducing its
ability to purchase ART. [1]
Due to the reduced availability of foreign currency, no
funds were made available to the Health Ministry for ART purchases in 2017 and 2018.[1]
Public hospitals had no ART medicines.[4] 10,000 HIV-positive people left
Venezuela to seek ART in other countries.[4] Some people bought expensive
treatments from foreign sources or on the black market. Many patients increased
the intervals between treatments. In 2017-18, the percent of patients receiving
ART decreased to 30%.[2] The number of people dying from AIDS increased from
2000/year to 5000.[2]
Nationwide ART access was
re-established in 2019 with funding from the World Bank through the Global
Fund. The percent of people
receiving ART (60%) and the number of deaths due to AIDS (2K) have returned to the
2015-levels. [2] 1400 HIV-positive people who left Venezuela for treatment
returned to the country by 2022.[5]
1.Irons, Rebecca, Resistance and the
regimen:the Microthanatopolitics of Venezuelan antiretroviral scarcity and HIV
drug adherence failures, Social Science & Medicine, October 2024
2. UNAIDS, Venezuela Data, https://www.unaids.org/en/regionscountries/countries/venezuela
3. Lancet,Venezuela’s economic crisis
hampers HIV/AIDS Treatment, March 18, 2017
4.New Humanitarian,Leave or Die. The
choice confronting HIV-positive Venezuelans, November 5, 2019
5.UNAIDS, Venezuela, 2022
Comments
Post a Comment